|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/19 | (2006.01) |
| A61P 25/20 | (2006.01) | ||
| A61K 45/06 | (2006.01) |
| (11) | Number of the document | 3335709 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17202548.8 |
| Date of filing the European patent application | 2013-12-13 | |
| (97) | Date of publication of the European application | 2018-06-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-12 |
| (46) | Date of publication of the claims translation | 2020-11-25 |
| (30) | Number | Date | Country code |
| 201261737695 P | 2012-12-14 | US |
| (72) |
ALLPHIN, Clark P., US
DESJARDIN, Michael, US
|
| (73) |
Jazz Pharmaceuticals Ireland Limited,
Waterloo Exchange, Waterloo Road,, Dublin 4,
IE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Gama-hidroksibutirato kompozicijos ir jų naudojimas sutrikimams gydyti |
| GAMMA-HYDROXYBUTYRATE COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2023-11-27 | 11 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-12-13 |